Speedus Corp (SPDE)
OTC PINK OTC PINK Primary 
XMIL Summary
Speedus Corp Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| TMB Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 1,040 | $0.1 | - | -$0.1 | -100% |
| RG Rafael Guijarro City National Bank Of Florida /MSD | 65,613 | $6.56 | - | -$6.56 | -100% |
| PB Patricia Buchholtz ECLECTIC ASSOCIATES Inc. /ADV | 90,936 | $1,420.28 | - | -$1,420.28 | -100% |
Speedus Corp (SPDE) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Speedus Corp ever had a stock split?
Speedus Corp Profile
| Software Industry | Information Technology Sector | Shant S. Hovnanian CEO | OTC PINK Exchange | 78463X889 CUSIP |
| US Country | 20 Employees | - Last Dividend | 3 Dec 2007 Last Split | - IPO Date |
Overview
Speedus Corp., originally established as SPEEDUS.COM, Inc., underwent a name change in May 2002 to reflect its evolved business scope. Founded in 1995, the company has its headquarters in Freehold, New Jersey. Its primary focus is on developing diagnostic decision support tools and telemedicine solutions aimed at enhancing medical practitioners' capabilities, including primary care physicians, pediatricians, and cardiologists, across the United States. Speedus Corp. operates through its subsidiaries, offering innovative medical devices and technology solutions that leverage computer-aided design and ultra-high speed storage systems. Besides its core healthcare technology products, the company is also engaged in managing a diverse portfolio of marketable securities, and equity and debt instruments in non-publicly traded companies. Furthermore, it holds a local multipoint distribution service license that boasts coverage of a substantial spectrum range in the New York City area, indicating a strategic asset within the telecommunications domain.
Products and Services
- Zargis Cardioscan device
This non-invasive diagnostic support tool is designed to revolutionize the way heart murmurs are detected and analyzed. By automatically examining acoustical data collected from a patient, the Cardioscan device can quickly determine the presence of a suspected diastolic or systolic murmur, streamlining the diagnostic process and enhancing patient care.
- ZargisTelemed portal
A telemedicine-based platform that provides an integrated solution for healthcare professionals to remotely diagnose and manage patient care. This portal is part of Speedus Corp.’s initiative to make healthcare more accessible and efficient by leveraging advanced technology.
- Signal X6 device
This innovative device captures heart and lung sounds through six adhesive acoustic sensors, offering a comprehensive tool for recording critical physiological data. The Signal X6 is a testament to Speedus Corp.'s commitment to advancing medical diagnostics through technology.
- Ultra-high speed storage systems
- JetX10 acceleration appliance
- JetPod
- JetNode expansion chassis
Speedus Corp. also ventures into the development and marketing of cutting-edge storage solutions, aimed at bolstering server network performance and other applications. These products, including the JetX10 acceleration appliance, JetPod, and JetNode expansion chassis, embody the company’s dedication to innovation beyond the medical field, potentially serving various industries with ultra-high speed data storage capabilities.
- Local multipoint distribution service license
This special FCC commercial operating license allows Speedus Corp. exclusive access to a significant spectrum range, between 150–300 MHz, in the New York City area. This asset not only facilitates the company's telecommunication services but also represents a strategic advantage in the competitive market.
